| The Hippo pathway and human cancer KF Harvey, X Zhang, DM Thomas Nature Reviews Cancer 13 (4), 246-257, 2013 | 2011 | 2013 |
| Translational biology of osteosarcoma M Kansara, MW Teng, MJ Smyth, DM Thomas Nature Reviews Cancer 14 (11), 722-735, 2014 | 1182 | 2014 |
| Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study D Thomas, R Henshaw, K Skubitz, S Chawla, A Staddon, JY Blay, ... The lancet oncology 11 (3), 275-280, 2010 | 783 | 2010 |
| The distinctive biology of cancer in adolescents and young adults A Bleyer, R Barr, B Hayes-Lattin, D Thomas, C Ellis, B Anderson, ... Nature Reviews Cancer 8 (4), 288-298, 2008 | 783 | 2008 |
| Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study S Chawla, R Henshaw, L Seeger, E Choy, JY Blay, S Ferrari, J Kroep, ... The lancet oncology 14 (9), 901-908, 2013 | 636 | 2013 |
| Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone DG Branstetter, SD Nelson, JC Manivel, JY Blay, S Chawla, DM Thomas, ... Clinical Cancer Research 18 (16), 4415-4424, 2012 | 486 | 2012 |
| Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2 E Zelzer, DJ Glotzer, C Hartmann, D Thomas, N Fukai, S Soker, BR Olsen Mechanisms of development 106 (1-2), 97-106, 2001 | 446 | 2001 |
| The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation DM Thomas, SA Carty, DM Piscopo, JS Lee, WF Wang, WC Forrester, ... Molecular cell 8 (2), 303-316, 2001 | 445 | 2001 |
| Clinical overview of MDM2/X-targeted therapies A Burgess, KM Chia, S Haupt, D Thomas, Y Haupt, E Lim Frontiers in oncology 6, 7, 2016 | 398 | 2016 |
| High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer M Krypuy, GM Newnham, DM Thomas, M Conron, A Dobrovic BMC cancer 6, 1-12, 2006 | 384 | 2006 |
| Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial WD Tap, H Gelderblom, E Palmerini, J Desai, S Bauer, JY Blay, T Alcindor, ... The Lancet 394 (10197), 478-487, 2019 | 382 | 2019 |
| FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor V Guagnano, A Kauffmann, S Wöhrle, C Stamm, M Ito, L Barys, A Pornon, ... Cancer discovery 2 (12), 1118-1133, 2012 | 361 | 2012 |
| Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice M Kansara, M Tsang, L Kodjabachian, NA Sims, MK Trivett, M Ehrich, ... The Journal of clinical investigation 119 (4), 837-851, 2009 | 341 | 2009 |
| Molecular pathogenesis of osteosarcoma M Kansara, DM Thomas DNA and cell biology 26 (1), 1-18, 2007 | 336 | 2007 |
| Li-Fraumeni syndrome: cancer risk assessment and clinical management KA McBride, ML Ballinger, E Killick, J Kirk, MHN Tattersall, RA Eeles, ... Nature reviews Clinical oncology 11 (5), 260-271, 2014 | 298 | 2014 |
| Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis PA Cassier, H Gelderblom, S Stacchiotti, D Thomas, RG Maki, JR Kroep, ... Cancer 118 (6), 1649-1655, 2012 | 297 | 2012 |
| Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer M Wong, C Mayoh, LMS Lau, DA Khuong-Quang, M Pinese, A Kumar, ... Nature medicine 26 (11), 1742-1753, 2020 | 292 | 2020 |
| Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing SQ Wong, J Li, AYC Tan, R Vedururu, JMB Pang, H Do, J Ellul, K Doig, ... BMC medical genomics 7, 1-10, 2014 | 282 | 2014 |
| Delivering precision oncology to patients with cancer J Mateo, L Steuten, P Aftimos, F André, M Davies, E Garralda, J Geissler, ... Nature medicine 28 (4), 658-665, 2022 | 275 | 2022 |
| Starting an adolescent and young adult program: some success stories and some obstacles to overcome A Ferrari, D Thomas, ARK Franklin, BM Hayes-Lattin, M Mascarin, ... Journal of Clinical Oncology 28 (32), 4850-4857, 2010 | 263 | 2010 |
